跳至主要内容
临床试验/IRCT20181005041238N1
IRCT20181005041238N1招募中早期 1 期

Effect of Zinc Supplementation and dietary weight loss on oxidative stress, steatosis, liver enzymes, glycemic and lipid profile Status in Non-Alcoholic Fatty Liver disease

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
早期 1 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients aged up to 18 years and more
  • an involvement of 33% of liver tissue with fats by ultrasound
  • BMI between 25-35

排除标准

  • An unwillingness of patients to participate in the study
  • breastfeeding
  • travel for more than 2 weeks
  • iron supplementation users
  • diabetes patients
  • alcohol consumption
  • patients with hepatitis B and C
  • hemochromatosis
  • Wilson's disease
  • patients with heart failure
  • kidney disease
  • autoimmunity
  • hypothyroidism or hyperthyroidism
  • Grade3 fatty liver patients
  • patients with any malabsorption
  • Weight changes over 5 kg In the last 3 months
  • follow a diet plan and certain physical activity
  • use of hepatotoxic drugs such as blockers, calcium channel, high doses of synthetic estrogens, methotrexate, chloroquine, tamoxifen, non-steroid anti-inflammatory drugs, amiodarone, statins and fibers
  • consumption drugs such as cefalexin, tetracycline and its derivatives, ceftibuten, deferiprone, antibiotics Quinolone is consumed

研究者

相似试验

zinc supplementation and non-alcoholic fatty liver... | 临床试验